- Home
- BME vs PRME Comparison
BME vs PRME Comparison
Compare BME & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- PRME
- Stock Information
- Founded
- BME 2005
- PRME 2019
- Country
- BME United States
- PRME United States
- Employees
- BME N/A
- PRME N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- PRME Medicinal Chemicals and Botanical Products
- Sector
- BME Finance
- PRME Health Care
- Exchange
- BME Nasdaq
- PRME Nasdaq
- Market Cap
- BME 462.3M
- PRME 191.7M
- IPO Year
- BME N/A
- PRME 2022
- Fundamental
- Price
- BME $36.35
- PRME $2.47
- Analyst Decision
- BME
- PRME Buy
- Analyst Count
- BME 0
- PRME 6
- Target Price
- BME N/A
- PRME $9.38
- AVG Volume (30 Days)
- BME 34.0K
- PRME 3.1M
- Earning Date
- BME 01-01-0001
- PRME 08-04-2025
- Dividend Yield
- BME 6.26%
- PRME N/A
- EPS Growth
- BME N/A
- PRME N/A
- EPS
- BME 1.44
- PRME N/A
- Revenue
- BME N/A
- PRME $3,846,000.00
- Revenue This Year
- BME N/A
- PRME $104.12
- Revenue Next Year
- BME N/A
- PRME $196.78
- P/E Ratio
- BME $28.37
- PRME N/A
- Revenue Growth
- BME N/A
- PRME 550.76
- 52 Week Low
- BME $35.53
- PRME $1.11
- 52 Week High
- BME $43.20
- PRME $6.75
- Technical
- Relative Strength Index (RSI)
- BME 55.94
- PRME 79.86
- Support Level
- BME $35.30
- PRME $1.56
- Resistance Level
- BME $36.49
- PRME $2.53
- Average True Range (ATR)
- BME 0.37
- PRME 0.25
- MACD
- BME 0.05
- PRME 0.12
- Stochastic Oscillator
- BME 82.27
- PRME 99.21
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.